Interaction of IGF signaling and the androgen receptor in prostate cancer progression.

Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*

Jones, J. I. W., & Clemmons, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,488 · see citing works

Insulin-like growth factors and their binding proteins: biological actions

Jones, J. I. (1995) · Endocrine Reviews · doi:10.1210/er.16.1.3 · Cited by 2,060 · see citing works

Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study

Chan, J. M., Stampfer, M. J., Giovannucci, E. L., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,992 · see citing works

Insulin-like growth factors and neoplasia

Pollak, M., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1387 · Cited by 1,465 · see citing works

Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors

Kousteni, S., Bellido, T., Plotkin, L. I., O’Brien, C. A., Bodenner, D., Li, H., Han, K., Gregorio, G. B. D., Katzenellenbogen, J. A., Katzenellenbogen, B. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00268-9 · Cited by 1,163 · see citing works

Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling Axis

Scher, H. I., & Sawyers, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4777 · Cited by 1,025 · see citing works

Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.

Čulig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., & Klocker, H. (1994) · PubMed · Cited by 938 · see citing works

Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors Dissociation from Transcriptional Activity

Kousteni, S. (2001) · Cell · doi:10.1016/s0092-8674(02)08100-x · Cited by 749 · see citing works

The Androgen Axis in Recurrent Prostate Cancer

Mohler, J. L., Gregory, C. W., Ford, O. H., Kim, D., Weaver, C. M., Petrusz, P., Wilson, E. M., & French, F. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1146-03 · Cited by 675 · see citing works

A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy.

Gregory, C. W., He, B., Johnson, R. T., Ford, O. H., Mohler, J. L., French, F. S., & Wilson, E. (2001) · PubMed · Cited by 603 · see citing works

Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer

Titus, M. A., Schell, M. J., Lih, F. B., Tomer, K. B., & Mohler, J. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0525 · Cited by 488 · see citing works

Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor.

Lin, H.-K., Yeh, S., Kang, H.-Y., & Chang, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121173298 · Cited by 401 · see citing works

Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence

Taplin, M., & Balk, S. P. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10653 · Cited by 392 · see citing works

Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease.

Hellawell, G. O., Turner, G. D. H., Davies, D. R., Poulsom, R., BREWSTER, S. F., & Macaulay, V. M. (2002) · PubMed · Cited by 376 · see citing works

Androgen Receptor Phosphorylation

Gioeli, D. G., Ficarro, S. B., Kwiek, J. J., Aaronson, D. S., Hancock, M., Catling, A. D., White, F. M., Christian, R. E., Settlage, R. E., Shabanowitz, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204131200 · Cited by 355 · see citing works

Insulin-like growth factor physiology and cancer risk

Pollak, M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00102-7 · Cited by 296 · see citing works

Cloning and Characterization of Androgen Receptor Coactivator, ARA55, in Human Prostate

Fujimoto, N., Yeh, S., Kang, H., Inui, S., Chang, H., Mizokami, A., & Chang, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8316 · Cited by 294 · see citing works

Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes.

Gregory, C. W., Hamil, K. G., Kim, D., Hall, S. H., Pretlow, T. G., Mohler, J. L., & French, F. S. (1998) · PubMed · Cited by 273 · see citing works

Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways.

Sadar, M. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7777 · Cited by 270 · see citing works

Adrenal glands of mouse and rat do not synthesize androgens

van Weerden, W. M., Bierings, H. G., Van Steenbrugge, G. J., De Jong, F. H., & Schröder, F. H. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90204-3 · Cited by 260 · see citing works

Identification of Domains of the Insulin-Like Growth Factor I Receptor That Are Required for Protection from Apoptosis

O’Connor, R., Kauffmann-Zeh, A., Liu, Y., Lehar, S. M., Evan, G. I., Baserga, R., & Blättler, W. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.427 · Cited by 255 · see citing works

Cloning and Characterization of Human Prostate Coactivator ARA54, a Novel Protein That Associates with the Androgen Receptor

Kang, H., Yeh, S., Fujimoto, N., & Chang, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8570 · Cited by 230 · see citing works

Serum Levels of Insulin-Like Growth Factor I (IGF-I), IGF-II, IGF-Binding Protein-3, and Prostate-Specific Antigen as Predictors of Clinical Prostate Cancer

Harman, S. M., Metter, E. J., Blackman, M. R., Landis, P., & Carter, H. B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6990 · Cited by 226 · see citing works

Survivin mediates resistance to antiandrogen therapy in prostate cancer

Zhang, M., Latham, D. E., Delaney, M. A., & Chakravarti, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208490 · Cited by 223 · see citing works

Androgens Up-regulate the Insulin-like Growth Factor-I Receptor in Prostate Cancer Cells

Pandini, G., Mineo, R., Frasca, F., Roberts, C. T., Marcelli, M., Vigneri, R., & Belfiore, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1837 · Cited by 208 · see citing works

Stress Kinase Signaling Regulates Androgen Receptor Phosphorylation, Transcription, and Localization

Gioeli, D. G., Black, B. E., Gordon, V. L., Spencer, A., Kesler, C. T., Eblen, S. T., Paschal, B. M., & Weber, M. J. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0351 · Cited by 175 · see citing works

Steroid 5α-Reductase Isozymes I and II in Recurrent Prostate Cancer

Titus, M. A., Gregory, C. W., Ford, O. H., Schell, M. J., Maygarden, S. J., & Mohler, J. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0738 · Cited by 174 · see citing works

In vivo Effects of the Human Type I Insulin-Like Growth Factor Receptor Antibody A12 on Androgen-Dependent and Androgen-Independent Xenograft Human Prostate Tumors

Wu, J. D., Odman, A., Higgins, L. M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1586 · Cited by 168 · see citing works

Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium.

Tennant, M. K., Thrasher, J. B., Twomey, P. A., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855837 · Cited by 162 · see citing works

LuCaP 35: A new model of prostate cancer progression to androgen independence

Corey, E., Quinn, J. E., Buhler, K. R., et al. (2003) · The Prostate · doi:10.1002/pros.10198 · Cited by 158 · see citing works

Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.

Miyake, H., Pollak, M., & Gleave, M. E. (2000) · PubMed · Cited by 144 · see citing works

Overexpression of Insulin-Like Growth Factor Binding Protein-5 Helps Accelerate Progression to Androgen-Independence in the Human Prostate LNCaP Tumor Model through Activation of Phosphatidylinositol 3'-Kinase Pathway

Miyake, H. (2000) · Endocrinology · doi:10.1210/en.141.6.2257 · Cited by 128 · see citing works

Insulin-Like Growth Factor Binding Protein-2 Binds to Cell Surface Proteoglycans in the Rat Brain Olfactory Bulb*

Russo, V. C., Bach, L. A., Fosang, A., et al. (1997) · Endocrinology · doi:10.1210/endo.138.11.5472 · Cited by 122 · see citing works

Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors.

Kiyama, S., Morrison, K. B., Zellweger, T., et al. (2003) · PubMed · Cited by 114 · see citing works

Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin- like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium

Tennant, M. K. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3774 · Cited by 94 · see citing works

Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin‐like growth factor I, insulin‐like growth factor binding protein 3, and insulin

Chen, C., Lewis, S. K., Voigt, L. F., et al. (2004) · Cancer · doi:10.1002/cncr.20727 · Cited by 92 · see citing works

Androgen and glucocorticoid receptors interact with insulin degrading enzyme.

Kupfer, S. R., Wilson, E. M., & French, F. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32038-0 · Cited by 83 · see citing works

Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.

Sadar, M. D., & Gleave, M. E. (2000) · PubMed · Cited by 74 · see citing works

Polymeric micellar paclitaxel phosphorylates Bcl-2 and induces apoptotic regression of androgen-independent LNCaP prostate tumors

Leung, S. Y. L., Jackson, J. K., Miyake, H., Burt, H. M., & Gleave, M. E. (2000) · The Prostate · doi:10.1002/1097-0045(20000701)44:2 · Cited by 67 · see citing works

Activation of the androgen receptor by polypeptide growth factors and cellular regulators

Čulig, Z., Hobisch, A., Cronauer, M. V., et al. (1995) · World Journal of Urology · doi:10.1007/bf00185971 · Cited by 66 · see citing works

Expression of the insulin-like growth factor I receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells.

Liu, Y., Lehar, S. M., Corvi, C., Payne, G., & O’Connor, R. (1998) · PubMed · Cited by 61 · see citing works

Transcriptional Activation of the Insulin-Like Growth Factor I Receptor Gene by the Kruppel-Like Factor 6 (KLF6) Tumor Suppressor Protein: Potential Interactions between KLF6 and p53

Rubinstein, M., Idelman, G., Plymate, S. R., et al. (2004) · Endocrinology · doi:10.1210/en.2004-0173 · Cited by 58 · see citing works

Reexpression of the Type 1 Insulin-Like Growth Factor Receptor Inhibits the Malignant Phenotype of Simian Virus 40 T Antigen Immortalized Human Prostate Epithelial Cells1

Plymate, S. R., Bae-Jump, V. L., Maddison, L. A., et al. (1997) · Endocrinology · doi:10.1210/endo.138.4.5071 · Cited by 56 · see citing works

A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model

Majeed, N., Blouin, M., Kaplan‐Lefko, P. J., Barry-Shaw, J., Greenberg, N. M., Gaudreau, P., Bismar, T. A., & Pollak, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208572 · Cited by 56 · see citing works

Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor.

Hongo, A., Yumet, G., Resnicoff, M., et al. (1998) · PubMed · Cited by 50 · see citing works

Androgen- and Estrogen-Dependent Regulation of Insulin-Degrading Enzyme in Subcellular Fractions of Rat Prostate and Uterus

Udrisar, D. P., Wanderley, M. I., Porto, R. C. C., Cardoso, C. L. P., Barbosa, M. C. L., Camberos, M. C., & Cresto, J. C. (2005) · Experimental Biology and Medicine · doi:10.1177/153537020523000706 · Cited by 43 · see citing works

Androgen receptor (AR) expression in AR‐negative prostate cancer cells results in differential effects of DHT and IGF‐I on proliferation and AR activity between localized and metastatic tumors

Plymate, S. R., Tennant, M. K., Culp, S. H., Woodke, L., Marcelli, M., Colman, I., Nelson, P. S., Carroll, J. M., Roberts, C. T., & Ware, J. L. (2004) · The Prostate · doi:10.1002/pros.20099 · Cited by 41 · see citing works

Type-1 insulin-like growth factor receptor reexpression in the malignant phenotype of SV40-T-immortalized human prostate epithelial cells enhances apoptosis

Plymate, S. R., Bae-Jump, V. L., Maddison, L. A., et al. (1997) · Endocrine · doi:10.1007/bf02778078 · Cited by 23 · see citing works

Reexpression of the Type 1 Insulin-Like Growth Factor Receptor Inhibits the Malignant Phenotype of Simian Virus 40 T Antigen Immortalized Human Prostate Epithelial Cells

Plymate, S. R. (1997) · Endocrinology · doi:10.1210/en.138.4.1728 · Cited by 23 · see citing works

Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer

Lamont, K. R., & Tindall, D. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0469 · Cited by 150 · see citing works

Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives

Hu, J., Wang, G., & Sun, T. (2017) · Tumor Biology · doi:10.1177/1010428317692259 · Cited by 25 · see citing works

Are androgen receptor variants a substitute for the full-length receptor?

Ji, L., der Steen, T. V., & Tindall, D. J. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.13 · Cited by 124 · see citing works

Response-Surface Modeling of the Effect of 5alpha-Dihydrotestosterone and Androgen Receptor Levels on the Response to the Androgen Antagonist Vinclozolin

Euling, S. Y. (2002) · Toxicological Sciences · doi:10.1093/toxsci/69.2.332 · Cited by 26 · see citing works

Pinostilbene inhibits full-length and splice variant of androgen receptor in prostate cancer

Shin, W., Han, S. H., Jo, K. W., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-43561-5 · Cited by 7 · see citing works

PRPF6 promotes androgen receptor/androgen receptor-variant 7 actions in castration-resistant prostate cancer cells

Liu, W., Wang, C., Wang, S., Zeng, K., Wei, S., Sun, N., Sun, G., Wang, M., Zou, R., Liu, W., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.50810 · Cited by 15 · see citing works